Your One Answer
3billion Mission
Diagnosis to treatment for rare disease patients
3billion made an effort to provide fast and accurate rare disease diagnoses
after stepping into the rare disease genetic testing field in 2016.
We have one mission, to create a world where rare disease patients
will not be excluded from diagnosis and treatment.
3billion's leaders
Changwon KeumChief Executive Officer
Sehwan KimChief Development Officer
Jungsul LeeChief Technology Officer
Kihyun KangChief Operating Officer
GoHun SeoChief Medical Officer
Soonil ParkChief Financial Officer
Sookjin LeeChief Business Officer
Hane LeeChief Genomics Officer
Kyoungyeul LeeChief Scientific Officer
Growth of
3billion
- April 2023Califormia Clinical Laboratory Licensed
- December 2022CLIA ceritified
Tested 40,000+ patients' genomes - June 2022Launched WGS diagnostic service, 3B-GENOME
- December 2021CAP accredited
Tested 20,000+ patients' genomes - May 2021Participated National Big Data Project hosted by
Korea Disease Control and Prevention Agency - December 2020Tested 10,000+ patients' genomes
- February 2020Opened genomic analysis laboratory
- February 2019Launched WES diagnostic service, 3B-EXOME
- January 2018Development of 3billion's variant analysis system
- March 2017Launched DTC genetic testing for rare diseases Beta Service
- October 20163billion, Inc, established